These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6271678

  • 1. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
    Sokol PA, Iglewski BH, Hager TA, Sadoff JC, Cross AS, McManus A, Farber BF, Iglewski WJ.
    Infect Immun; 1981 Oct; 34(1):147-53. PubMed ID: 6271678
    [Abstract] [Full Text] [Related]

  • 2. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.
    Iglewski BH, Sadoff J, Bjorn MJ, Maxwell ES.
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3211-5. PubMed ID: 210453
    [Abstract] [Full Text] [Related]

  • 3. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
    Hamood AN, Griswold JA, Duhan CM.
    J Surg Res; 1996 Mar; 61(2):425-32. PubMed ID: 8656619
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.
    Nicas TI, Iglewski BH.
    Infect Immun; 1984 Aug; 45(2):470-4. PubMed ID: 6086529
    [Abstract] [Full Text] [Related]

  • 5. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    Antibiot Chemother (1971); 1985 Aug; 36():40-8. PubMed ID: 2988426
    [Abstract] [Full Text] [Related]

  • 6. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
    Grimwood K, Semple RA, Rabin HR, Sokol PA, Woods DE.
    Pediatr Pulmonol; 1993 Mar; 15(3):135-9. PubMed ID: 8327274
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
    Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA.
    J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
    [Abstract] [Full Text] [Related]

  • 8. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA, Collier RJ.
    Curr Top Microbiol Immunol; 1992 Aug; 175():27-41. PubMed ID: 1628498
    [No Abstract] [Full Text] [Related]

  • 9. Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.
    Coburn J, Dillon ST, Iglewski BH, Gill DM.
    Infect Immun; 1989 Mar; 57(3):996-8. PubMed ID: 2492977
    [Abstract] [Full Text] [Related]

  • 10. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.
    Nicas TI, Frank DW, Stenzel P, Lile JD, Iglewski BH.
    Eur J Clin Microbiol; 1985 Apr; 4(2):175-9. PubMed ID: 2988945
    [Abstract] [Full Text] [Related]

  • 11. Bacterial protein toxins with latent ADP-ribosyl transferases activities.
    Lai CY.
    Adv Enzymol Relat Areas Mol Biol; 1986 Apr; 58():99-140. PubMed ID: 3012972
    [No Abstract] [Full Text] [Related]

  • 12. Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S.
    Knight DA, Barbieri JT.
    Infect Immun; 1997 Aug; 65(8):3304-9. PubMed ID: 9234791
    [Abstract] [Full Text] [Related]

  • 13. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H, Iglewski WJ.
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [Abstract] [Full Text] [Related]

  • 14. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.
    Bjorn MJ, Pavlovskis OR, Thompson MR, Iglewski BH.
    Infect Immun; 1979 Jun; 24(3):837-42. PubMed ID: 112058
    [Abstract] [Full Text] [Related]

  • 15. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
    Frank DW, Nair G, Schweizer HP.
    Infect Immun; 1994 Feb; 62(2):554-63. PubMed ID: 8300213
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S, Tai PC.
    Curr Top Microbiol Immunol; 1985 Feb; 118():53-69. PubMed ID: 2414071
    [No Abstract] [Full Text] [Related]

  • 17. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI, Iglewski BH.
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [Abstract] [Full Text] [Related]

  • 18. Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS.
    Riese MJ, Barbieri JT.
    Infect Immun; 2002 Apr; 70(4):2230-2. PubMed ID: 11895993
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity.
    Coburn J, Kane AV, Feig L, Gill DM.
    J Biol Chem; 1991 Apr 05; 266(10):6438-46. PubMed ID: 1901061
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M, Dyda F, Benhar I, Pastan I, Davies DR.
    Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):6902-6. PubMed ID: 8692916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.